Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00688519 · ClinicalTrials.gov registry record · Phase 3
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
A Phase 3 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 336
- Enrollment target
NCT00688519 is a Phase 3 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 336 participants.
The verdict
NCT00688519, a Phase 3 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 336 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the safety and efficacy of U0267 in subjects with plaque-type psoriasis.
Interventions
- DRUG Vehicle
- DRUG U0267
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00688519
The ClinicalTrials.gov registry entry for NCT00688519 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 336 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT00688519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00688519 about?
NCT00688519 is a clinical study titled "Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies". The purpose of the study is to demonstrate the safety and efficacy of U0267 in subjects with plaque-type psoriasis.
What is the current status of trial NCT00688519?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 336 participants. The study started on 2008-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00688519?
The interventions under investigation include: Vehicle (DRUG), U0267 (DRUG).
Who is sponsoring clinical trial NCT00688519?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.